Lobbying Spend
—
Filings
46
Firms Hired
3
Active Period
2019–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Consolidated Appropriations Act, 2021
2020 · fourth_quarter · Firm: THORN RUN PARTNERS
Issues related to orphan drugs and the value of innovative medicines. Legislation supporting the Orphan Drug Act. Issues regarding pharmaceutical vial sizes. H.R. 133, Consolidating Appropriations Act, 2021.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 133
Issues related to orphan drugs and the value of innovative medicines. Legislation supporting the Orphan Drug Act. The Cares Act (P.L. 116-136), all provisions pertaining to corporate tax. H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6800
Patient Protection and Affordable Care Enhancement Act
2020 · second_quarter · Firm: THORN RUN PARTNERS
Issues related to orphan drugs and the value of innovative medicines. Legislation supporting the Orphan Drug Act. Patient Protection and Affordable Care Enhancement Act (H.R. 1425). The Cares Act, PL 116-136, all provisions pertaining to corporate tax, and CMS home infusion benefits. H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1425
Issues related to orphan drugs and the value of innovative medicines. Legislation supporting the Orphan Drug Act. Patient Protection and Affordable Care Enhancement Act (H.R. 1425). The Cares Act, PL 116-136, all provisions pertaining to corporate tax, and CMS home infusion benefits. H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6800
Elijah E. Cummings Lower Drug Costs Now Act
2020 · first_quarter · Firm: THORN RUN PARTNERS
Issues related to orphan drugs and the value of innovative medicines. Legislation supporting the Orphan Drug Act. Legislation encouraging research for cystinosis. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3
Elijah E. Cummings Lower Drug Costs Now Act
2019 · fourth_quarter · Firm: THORN RUN PARTNERS
Issues related to orphan drugs and the value of innovative medicines. Legislation supporting the Orphan Drug Act. Legislation encouraging research for cystinosis. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3
Source: Senate LDA